# Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care

> **NCT03410446** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 22 (actual)

## Conditions studied

- Depression
- Cancer
- Palliative Care

## Interventions

- **DRUG:** Ketamine Hydrochloride

## Key facts

- **NCT ID:** NCT03410446
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-16
- **Primary completion:** 2021-11-27
- **Final completion:** 2021-11-27
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2022-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03410446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03410446, "Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03410446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*